Lactose India [LACTOSE] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Lactose India Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Lactose India Ltd. wins in 7 metrics, Sun Pharmaceutical Industries Ltd. wins in 12 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lactose India Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 30.45 36.73 Lactose India Ltd.
Price-to-Book Ratio 2.38 5.15 Lactose India Ltd.
Debt-to-Equity Ratio 86.78 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 0.21 3.59 Lactose India Ltd.
EV/EBITDA 12.54 23.61 Lactose India Ltd.
Profit Margin (TTM) 3.32% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 4.45% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 4.45% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 8.79% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 3.87% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-146.70M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return 20.41% 7.25% Lactose India Ltd.
Price-to-Sales Ratio (TTM) 1.02 7.05 Lactose India Ltd.
Enterprise Value $1.98B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 1.36 6.66 Lactose India Ltd.
Gross Profit Margin (TTM) 27.83% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $118 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $3.86 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.39 0.11 Sun Pharmaceutical Industries Ltd.

Lactose India Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

LACTOSE
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lactose India Ltd.5.86%-6.31%-3.48%17.55%-7.12%3.88%
Sun Pharmaceutical Industries Ltd.-0.08%-2.77%-1.84%2.13%-0.53%4.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lactose India Ltd.20.41%127.85%280.87%63.03%1,621.05%19,298.31%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Lactose India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricLACTOSESUNPHARMA
Market Information
Market Cap i₹1.48B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i9,3463,903,142
90 Day Avg. Volume i7,2043,253,866
Last Close₹114.65₹1,788.50
52 Week Range₹76.01 - ₹136.70₹1,548.00 - ₹1,916.60
% from 52W High-16.13%-6.68%
All-Time High₹247.40 (Dec 09, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-53.66%-8.77%
Growth Metrics
Quarterly Revenue Growth0.28%0.14%
Quarterly Earnings Growth1.42%0.16%
Financial Health
Profit Margin (TTM) i0.03%0.19%
Operating Margin (TTM) i0.04%0.26%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i86.786.68
Cash & Liquidity
Book Value per Share (MRQ)₹49.43₹324.46
Cash per Share (MRQ)₹3.25₹115.87
Operating Cash Flow (TTM) i₹-49,118,000₹110.84B
Levered Free Cash Flow (TTM) i₹51.63M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Lactose India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricLACTOSE (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.4536.73
Forward P/E iN/A29.48
PEG Ratio i0.213.59
Price to Sales (TTM) i1.027.05
Price to Book (MRQ) i2.385.15
Market Capitalization
Market Capitalization i₹1.48B₹3.88T
Enterprise Value i₹1.98B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i1.366.66
Enterprise to EBITDA i12.5423.61
Risk & Other Metrics
Beta i0.390.11
Book Value per Share (MRQ) i₹49.43₹324.46

Financial Statements Comparison: Lactose India Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLACTOSE (2025)SUNPHARMA (2025)
Revenue/Sales i1.16B520.41B
Cost of Goods Sold i772.10M121.98B
COGS % of Revenue i66.4%23.4%
Gross Profit i390.56M398.44B
Gross Margin i33.6%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i115.95M125.81B
Operating Margin i10.0%24.2%
EBITDA i175.41M167.25B
EBITDA Margin i15.1%32.1%
Pre-Tax Income i69.18M137.52B
Pre-Tax Income % of Revenue i5.9%26.4%
Income Tax i17.55M27.72B
Income Tax % of Revenue i1.5%5.3%
Net Income (Profit) i51.63M109.65B
Profit Margin i4.4%21.1%

Balance Sheet & Liquidity Metrics

MetricLACTOSE (2025)SUNPHARMA (2025)
Cash & Equivalents i44.81M102.69B
Total Current Assets i573.26M526.24B
Total Current Assets % of Revenue i49.3%101.1%
Total Current Liabilities i448.90M181.94B
Total Current Liabilities % of Revenue i38.6%35.0%
Long-Term Debt i259.33M3.58B
Long-Term Debt % of Revenue i22.3%0.7%
Total Shareholders Equity i587.40M724.86B
Retained Earnings i260.03M578.62B
Retained Earnings % of Revenue i22.4%111.2%
Property, Plant & Equipment i12.74M100.36B

Cash Flow Statement Comparison

MetricLACTOSE (2025)SUNPHARMA (2025)
Operating Cash Flow i-49.12M110.84B
Operating Cash Flow % of Revenue i-4.2%21.3%
Capital Expenditures i-139.17M-20.68B
Free Cash Flow i-146.70M119.44B
FCF Margin i-12.6%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricLACTOSESUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.59M2.40B
Float Shares i5.19M1.07B
% Held by Insiders i58.73%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i41.27%15.69%

Dividend Analysis & Yield Comparison: Lactose India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricLACTOSESUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026